We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Healthcare Provider and Medical IT Vendor Offer Osteoporosis Assessment

By MedImaging International staff writers
Posted on 27 Sep 2016
Print article
Image: The OneScreen Digital X-Ray Radiogrammetry (DXR) exam of the hand (Photo courtesy of Sectra).
Image: The OneScreen Digital X-Ray Radiogrammetry (DXR) exam of the hand (Photo courtesy of Sectra).
A private care provider in Sweden and a large medical Internet Technology (IT) vendor have join forces to offer preventive bone health testing for people with osteoporosis risk factors.

The screening program is intended to enable preventive measures to be taken, which can reduce or avoid the risk of fractures. Half of all women in Sweden will suffer from a painful bone fracture, usually following menopause, as a result of osteoporosis, which can lead to long-term disabilities.

The OneScreen bone density analysis technology was developed by Sectra (Linköping, Sweden) and is being used by Unilabs (Stockholm, Sweden), a private care provider, to provide preventive bone health testing. The examination is carried out either together with a mammography exam at Unilabs, or separately at a Unilabs radiology clinic. The Sectra OneScreen test uses Digital X-Ray Radiogrammetry (DXR), and is based on a radiology image of the hand. Those individuals who are determined to have a high risk of osteoporosis will receive a further exam and treatment if needed. Studies have shown that the Sectra OneScreen technology can be used for effective osteoporosis care, to identify those patients at risk.

Charlotta Wikström, head of Unilabs’ radiology operation, said, “Thanks to our cooperation with Sectra, we now have the opportunity to offer a complete treatment chain for this serious disease, from initial risk assessment to follow-up and possibly further examinations and treatment.”

Related Links:
Sectra
Unilabs
Silver Member
X-Ray QA Meter
T3 AD Pro
New
Needle Guide Disposable Kit
Verza
New
MRI Infusion Workstation
BeneFusion MRI Station
X-Ray Illuminator
X-Ray Viewbox Illuminators

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.